期刊文献+

抗中性粒细胞胞浆抗体在系统性红斑狼疮伴有血管炎病变中的临床意义 被引量:3

Study on the relationship between antineutrophil cytoplasmic antibodies and vasculitis in Systemic Lupus Erythematosis
下载PDF
导出
摘要 目的探讨抗中性粒细胞胞浆抗体(ANCA)在系统性红斑狼疮(SLE)伴有血管炎病变中的临床意义。方法收集138例SLE住院病例的临床和实验室资料,间接免疫荧光(IIF)方法检测患者血清AN-CA,ANCA阳性者加做髓过氧物酶(MPO)、蛋白酶3(PR3)的酶联免疫检测(ELISA)。对患者进行SLEDAI评分评判疾病活动性,比较间接免疫荧光法检测ANCA阳性组与阴性组血管炎病变发生比率及疾病活动度有无差异。结果①间接免疫荧光法检测ANCA在SLE中的阳性率是15.2%,其中核周型ANCA阳性14.5%,胞浆型ANCA阳性0.7%;②SLE患者皮肤血管炎病变(包括面部红斑、结节红斑、雷诺现象、网状青斑、紫癜)发生率78.3%,肺间质病变(包括肺间质纤维化及出血性肺泡炎)发生率6.5%,肾脏病变(血尿及蛋白尿)发生率64.5%,ANCA阳性及ANCA阴性组SLE患者血管炎表现,包括皮肤血管炎(P=0.442)、肺间质病变(P=1.000)、肾脏病变(P=0.471)差异无统计学意义。③对所有SLE患者进行SLEDAI评分,ANCA阳性组及ANCA阴性组SLE活动性差异无统计学意义(P=0.879)。结论采用间接免疫荧光法检测ANCA的结果与SLE血管炎表现及病情活动无明显相关性。 Objective To investigate the clinical significance of antineutrophil cytoplasmic antibodies (ANCA ) in vasculitis in Systemic Lupus Erythematosis (SLE). Methods 138 SLE patients' clinical manifestations (including laboratory indexes) were collected, ANCA was detected by indirect immunofluorescence (IIF) , and the positive ones were detected MPO and PR3 by ELtSA. We accessed the disease activity as measured by SLEDAI and compared the SLE vasculitis clinical manifestations and disease activity between IIF-ANCA-positive and negative patients. Results (1) As detected by IIF technique, ANCA were present in 15.2 % of SLE patients, and 14.5% of them were peripheral nuclear ANCA. (2) Cutaneous vasculitis was found in 78.3% of patients with SLE ,nephritis 64.5% ,interstitial lung disease 6.5%. No association was found between IIF-ANCA and any of the vaseulitis clinical manifestation at the time of assessment ( cutaneous vasculitis : P = 0. 442, interstitial lung disease: P = 1. 000 ), nephritis : P = 0.472. (3) No statisti- cally significant difference was found to be existed between SLEDAI of IIF-ANCA positive and negative patients ( P = 0.8790). Conclusion No correlation between IIF-ANCA and vasculitis in SLE or acitivitv of SLE.
出处 《中国临床保健杂志》 CAS 2009年第5期452-454,共3页 Chinese Journal of Clinical Healthcare
关键词 红斑狼疮 系统性/继发性 抗体 抗中性白细胞胞质 髓过氧化物酶 荧光抗体技术 间接 Lupus erythematosus systemic/secondary Antibodies antineutrophil cytoplasmic Myeloperoxidase Fluorescent antibody technique indirect
  • 相关文献

参考文献3

二级参考文献8

  • 1Zhao M H,Clin Exp Immunol,1995年,99卷,49页
  • 2蒋明,风湿病学(第2版),1995年,1037页
  • 3Molnar K,Kovacs L,Kiss M,et al.Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythemato sus[J].Clin Exp Dermatol,2002,27(1):56-61.
  • 4Wiik A,Rasmussen N,Wieslander J.Methods to detect autoantibodies to neutrophilic granulocytes[J].Manual Biol Markers Dis,1993,A9:1-14.
  • 5Chin HJ,Ahn C,Lim CS,et al.Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis[J].Am J Nephrol,2000,20(1):57-63.
  • 6Manolova I,Danchiva M,Halacheva K.Anti-neutrophil cyto plasmic antibodies in patients with systemic lupus erythemato sus:Prevalence,antigen specificity and clinical associations[J].Rheumatol Int,2001,20:197-204.
  • 7唐福林,石颜军.抗中性粒细胞胞浆抗体检测对血管炎的诊断价值[J].中华结核和呼吸杂志,1999,22(1):23-24. 被引量:9
  • 8李光迪,刘芳.系统性红斑狼疮患者抗中性粒细胞胞浆抗体检测结果的分析[J].国外医学(临床生物化学与检验学分册),2003,24(2):106-107. 被引量:2

共引文献15

同被引文献13

  • 1Galeazzi M, Morozzi G, Sebastiani GD, et al. Anti-neutrophil cyto- plasmic antibodies in 566 european patients with systemic lupus erythema- tosus: prevalence, clinical associations and correlation with other an- toantibodies. European concerted action on the immunogenetics of SLE [J]. Clin Exp Rheumatol, 1998, 16(5) : 541-546.
  • 2Nishiya K, Chikazawa H, Nishimura S, et al. Anti-neutrophil cyto- plasmic antibody in patients with systemic lupus erythematosus is unrelat- ed to clinical features[ J]. Clin Rheumatol, 1997, 16( 1 ) : 70-75.
  • 3Schnabel A, Csernok E, Isenberg DA, et al. Antineutrophil cyto- plasmic antibodies in systemic lupus erythematosus. Prevalence, speeifici- ties, and clinical significance[J]. Arthritis Rheum, 1995, 38 (5): 633-637.
  • 4Manolova I, Daneheva M, Halacheva K. Antineutrophil cytoplas- mic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations[ J]. Rheumatol Int, 2001, 20(5) : 197-204.
  • 5Hochberg MC. Updating the American college of rheumatology re- vised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1997, 40(9) : 1725.
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. The committee prognosis studies in SLE derivation of the SLEDAI: a disease activity in- dex for lupus patients[J]. Arthritis Rheum, 1992, 35(6) : 630-640.
  • 7Davis DJ, Morad JE, Niall JF, et al. Segmental necrotizing glomer- ulonephritis with antineutrophil antibody: Possible arbovirus aetiology? [J]. Br Med J, 1982, 285(2) : 606-616.
  • 8Jennette JC, Falk R J, Andrassy K, et al. Nomenclature of system- ic vasculitides. Proposal of an international consensus conference [ J ]. Ar- thrifts Rheum. 1994. 37(23 : 187-192.
  • 9罗婷,赵明辉,马圣清.抗中性粒细胞胞浆抗体在系统性红斑狼疮中的临床意义[J].中华皮肤科杂志,1999,32(1):20-21. 被引量:13
  • 10杨广宇,苏芳,陈永健.SLE患者检测血清ANCA的临床价值[J].放射免疫学杂志,2012,25(3):297-299. 被引量:5

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部